Abstract
Early stages of transcription from eukaryotic promoters include two principal events: the capping of newly synthesized mRNA and the transition of RNA polymerase II from the preinitiation complex to the productive elongation state. The capping checkpoint model implies that these events are tightly coupled, which is necessary for ensuring the proper capping of newly synthesized mRNA. Recent findings also show that the capping machinery has a wider effect on transcription and the entire gene expression process. The molecular basis of these phenomena is discussed.
Keywords: capping checkpoint, mRNA capping, promoter, transcription pausing, transcription
Introduction
A characteristic feature of eukaryotic mRNAs is the presence of the cap structure at the 5′-end. This structure consists of an inverted 7-methylguanosine linked to the first-transcribed nucleotide of a newly synthesized transcript and is subsequently bound by the cap-binding protein complex (CBC). The major cap function is to stabilize nascent transcripts by protecting mRNA from 5′-exonucleases [1,2]. In addition, the cap helps to recruit factors necessary for splicing, 3′-end processing, export, and translation [3,4].
The mRNA capping machinery has three basic activities: RNA 5′-triphosphatase (RT), guanylyltransferase (GT), and RNA guanine-N7 methyltransferase (RNMT). In yeast, there are three separate enzymes responsible for these activities. The RT and GT enzymes are combined in one functional complex in Saccharomyces cerevisiae but function separately in Schizosaccharomyces pombe [5,6]. In metazoans, the first two activities are performed by the same capping enzyme (CE), while the methyltransferase activity resides in the RNMT–RAM complex in which RNMT is the catalytic subunit and RAM is the activating subunit stimulating RNMT activity [7–9]. Moreover, the capping machinery includes cap-specific mRNA (nucleoside-2′-O-)-methyltransferases CMTR1 and CMTR2 (CMTr) and also recently described cap-specific adenosine N6-methyltransferase (CAPAM) [10].
The eukaryotic mRNA capping process does not always proceed to completion [11]. In mammals, proteins of the DXO/Dom3Z and XRN families serve as surveillance proteins in 5′-end capping quality control. In particular, decapping exoribonuclease DXO degrades capped but unmethylated pre-mRNA [12,13]. In S. cerevisiae, there are partially redundant machineries for RNA cap quality control: Rai1-Rat1 and Ydr370C/Dxo1 [11,14–16].
Capping occurs co-transcriptionally with the capping and transcriptional machineries being tightly coupled. Below, we describe current views on the connection between the capping process and transcriptional events. Table 1 shows the list of factors participating in the establishment of this connection in different organisms.
Table 1. Factors participating in capping–transcription coupling.
| Protein/protein complex | S. cerevisiae, budding yeast | S. pombe, fission yeast | Drosophila melanogaster, fly | Mus musculus, mouse | Homo sapiens, human |
|---|---|---|---|---|---|
| RNA GT | Ceg1 | Pce1 | mRNA-cap | RNGTT | RNGTT |
| 5′ phosphatase, RT (RNGTT) | Cet1 | Pct1 | |||
| MT- RNMT | Abd1 | Pcm1 | l(2)35Bd | RNMT | RNMT |
| Cap-specific mRNA (nucleoside-2′-O-)-methyltransferase (CMTr) | - | - | CG6379, aft | CMTR1, CMTR2 | CMTR1, CMTR2 |
| CAPAM | - | - | CG11399 | PCIF1 | PCIF1 |
| CBC | Sto1+cbc2 | cbc1+cbc2 | Cbp80+ Cbp20 | NCBP1+NCBP2 | NCBP1+ NCBP2 |
| TFIIH kinase subunit | Kin28 | Mcs6 | Cdk7 | Cdk7 | Cdk7 |
| Phosphatase of Pol II CTD (CPF) | Ssu72 | Ssu72 | Ssu72 | Ssu72 | Ssu72 |
| Positive transcription elongation factor (P-TEFb) | Ctk1+Ctk2+ Ctk3, Bur1+Bur2 | Cdk9+Pch1 | Cdk9+ CycT | Cdk9+CCNT1 | Cdk9+ CCNT1 |
| DRB sensitivity-inducing factor (DSIF) | Spt4+Spt5 | Spt4+Spt5 | SPT4+SPT5 | (SUPT4a/SUPT4b)+SUPT5 | SUPT4H1+SUPT5H |
| Negative elongation factor (NELF) | - | - | NELFA+ NELFB+ TH1+ NELFE |
NELFA+ NELFB+ NELFC/D+ NELFE |
NELFA+ NELFB+ NELFC/D+ NELFE |
| Polyadenylate-binding protein-interacting protein 2 (Paip2) | - | - | Paip2 | Paip2a, Paip2b | Paip2a, Paip2b |
Abbreviations: Cdk7, cyclin-dependent kinase 7; PCIF1, cap-specific adenosine N6-methyltransferase; Pol II, RNA Polymerase II.
Capping checkpoint model
RNA Polymerase II (Pol II)-dependent transcription is a complex process regulated by multiple factors and signals, which involves several checkpoints to ensure proper mRNA synthesis and assembly of mRNA–protein complex [17,18]. The principal checkpoints include proper mRNA capping, splicing, and 3′-end formation.
Eukaryotic transcription occurs in the following basic stages: the assembly of preinitiation complex, initiation, elongation, and termination. The initiation–elongation transition is further divided into ‘early elongation’ and ‘productive elongation.’ These two substages are separated by Pol II pausing: after transcription of approximately 20–60 nucleotides, Pol II stops the synthesis until a specific signal comes [19]. Early studies on this phenomenon on the hsp model genes have indicated that the pausing is connected with mRNA cap formation [20].
The capping checkpoint model suggests that Pol II pauses at promoter-proximal region to ensure mRNA capping prior to the onset of productive elongation. Arrest of early elongation ensures the recruitment of the CEs, which in turn attract other factors to cancel the arrest. Capping occurs progressively as Pol II moves through the pause region: the most proximal paused RNAs are largely uncapped, while more distal are completely capped [20]. Capping in this context means the addition of capping guanosine, while the time point of its methylation during transcription has not yet been determined with certainty. That is why the term ‘capping’ refers below to the event of guanosine addition, with cases of its methylation being specifically indicated.
There are several factors ensuring proper transition though the pausing stage [21]. Following the transcription initiation, the DRB sensitivity-inducing factor (DSIF) binds Pol II [22,23] and recruits the negative elongation factor (NELF) on to chromatin [24]. The latter causes a transcriptional pause, during which the capping machinery is recruited. During early elongation, the Pol II C-terminal domain (Pol II CTD) is phosphorylated at the Ser5 residue by the cyclin-dependent kinase 7 (Cdk7), a subunit of TFIIH. Ser5-phosphorylated Pol II CTD and Spt5 subunit of DSIF recruit the capping machinery [25,26]. The recruitment of CE can relieve the action of NELF and provide a platform for the positive transcription elongation factor (P-TEFb) loading [27,28]. The latter phosphorylates Ser2 of Pol II CTD [29], DSIF [30,31], and NELF factors [32]. As a result, phosphorylated NELF dissociates and the paused Pol II is released into productive elongation (Figure 1).
Figure 1. Early stages of transcription.
Capping and transcription factors acting jointly at early stages of transcription: initiation, pausing, and elongation. The factors crucial for transcription–capping interplay are shown. Abbreviation: PIC, preinitiation complex.
Capping machinery functioning depends on transcription
The mRNA capping apparatus and early elongation factors show tight connection in the nucleus. The central players connecting these machineries are Pol II CTD and Spt5 [28,33,34]. Indeed, Pol II with a truncated CTD displays capping defects [35]. Pol II CTD has a specific phosphorylation pattern, which depends on the stage of the transcription process [36], and the recruitment and functioning of CEs depend on this pattern [37].
It is the phosphorylated CTD that couples transcription with capping [37]. More precisely, its phosphorylation at Ser5 (not at Ser2) stimulates capping activity [38]. Ser5 phosphorylation on the promoter provides for correct early mRNA processing. Ser5-phosphorylated Pol II has been shown to co-purify with the capping machinery and TFIIH kinase [39]. Recent research has shown that Ser7 phosphorylation is also important for capping: it is necessary for GT Ceg1 association with Pol II in yeast [40].
Ser5-phosphorylated Pol II CTD and Spt5 in fission yeast interact with GT Pce1 and triphosphatase Pct1 [41,42]. In budding yeast, RNA GT Ceg1 binds to Ser5-phosphorylated CTD and recruits the Cet1 triphosphatase to Pol II, and it has also been shown that Ceg1 and Abd1 bind directly and independently to phospho-CTD [43,44].
Ser5 phosphorylation is also important for RNGTT binding and its activity in mammals [44,45]. Human RNMT recruitment also depends on Ser5 phosphorylation [46], with RNMT forming ternary complexes with the CE and the elongating form of Pol II [47]. The GT domain of mouse CE Mce1 binds to the phosphorylated CTD [44]. Moreover, the mammalian GT is activated allosterically by binding to Ser5-phosphorylated CTD [38].
Thus, the connection of capping machinery with Ser5-phosphorylated Pol II CTD is a conserved feature [38]. However, the location and composition of the CTD-binding site in the mammalian CE is distinct from that in the yeast CE, which recognizes the same CTD primary structure [45].
In budding yeast, the recruitment of all three CEs to the 5′-ends of transcribed genes requires Kin28 [25,48,49]. This is a major kinase responsible for Ser5 phosphorylation (an ortholog of Cdk7 subunit of TFIIH in Metazoa). Inhibition of human Cdk7 activity results in reduced CE recruitment, with consequent decrease in mRNA capping, and increased Pol II promoter-proximal pausing [50–52].
As expected, Pol II CTD phosphatases, which act during productive elongation, antagonize CE binding. Thus, phosphatase FCP1 is necessary for the dissociation of the CE from Pol II CTD in mammals [49].
However, phosphorylated Pol II CTD alone is not sufficient for efficient capping [53]. There is a CTD-independent, but Pol II-mediated mechanism that functions in parallel with CTD-dependent processes to ensure optimal capping [54]. The mRNA CE in yeast requires two interfaces for the interaction with Pol II: Ser5-phosphorylated CTD and the multihelical foot domain of Rpb1. The latter contributes to the specificity of CE interaction with Pol II [55]. Mutations in the foot domain or the factors associated with it lead to increase in Ser5 phosphorylation [56,57].
In S. cerevisiae, Cet1 and Ceg1 interact with Pol II in heterotetrameric Cet12Ceg12 form [4,58]. The interaction between Ceg1 and the phosphorylated Pol II CTD is well studied [45,59], but Cet1 also forms extensive interactions with the transcribing Pol II complex outside of CTD. Ceg1 appears to be mobile and adopt multiple conformations in the transcribing complex. Contacts with Pol II subunit Rpb7 have also been observed [58]. Thus, the combination of CTD-independent and CTD-dependent tethering mechanisms plays a dominant role in activation of co-transcriptional capping.
Another transcription factor contributing to capping machinery recruitment is the Spt5 protein, a subunit of early Pol II elongation factor DSIF. Spt5 carries a CTD that plays a role similar to that of Pol II CTD. Both Spt5 and Pol II CTDs are important for the recruitment of CEs [34]. In fission yeast, triphosphatase Pct1 and GT Pce1 bind independently to the elongation factor Spt5 [42]. In budding yeast, Spt5 contributes to stable recruitment of the mRNA CEs Cet1, Ceg1, and Abd1 [33].
There is experimental evidence for the concept of an ‘Spt5 CTD code,’ similar to that of Pol II CTD. According to this concept, the Spt5 CTD is structurally flexible and can adopt different conformations that are templated by particular cellular Spt5 CTD receptor proteins; moreover, threonine phosphorylation of the Spt5 CTD repeat inscribes a binary on-off switch that is read by diverse CTD receptors, each in its own distinctive manner [60]. Unlike with the Pol II CTD, phosphorylation of Spt5 CTD by P-TEFb blocks the Spt5–Pce1 interaction [59].
It is noteworthy that the way of CEs recruitment may be species-specific. In budding yeast, the cap methyltransferase Abd1 interacts directly with phosphorylated serine 5 CTD Pol II, whereas the cap methyltransferase Pcm1 in fission yeast is recruited in a complex with Cdk9/Pch1 (P-TEFb) [49,61], with Cdk9/Pch1 apparently targeting the capping apparatus to the transcriptional complex [61].
One more general transcription factor participates in proper capping. This is the TFIIB tip region, which is required for appropriate levels of serine 5 CTD Pol II phosphorylation and mRNA capping [62].
In mammals, the first- and second-transcribed nucleotides can also be O-2 methylated by CMTR1 and CMTR2 enzymes [63,64]. This modification has a role in translation initiation and identification of transcripts as ‘self’ in innate immunity [4]. CMTR1 is recruited to Ser5-phosphorylated Pol II CTD early in transcription [65].
Recently, a novel methyltransferase CAPAM was discovered. It catalyzes N6-methylation of the first-transcribed adenosine [10,66,67]. CAPAM was identified as Ser5-phosphorylated CTD-interacting factor 1 (PCIF1) [10,68]. While initially CAPAM was found to have a negative effect on RNA Pol II-dependent transcription of a model gene [68], later transcriptome-wide analyses showed its gene-specific effect on transcription [66,69–71].
Thus, there are a number of interactions between CEs and Pol II and Spt5. These interactions are crucial for the recruitment and functioning of CEs. The connection between the capping machinery and transcriptional apparatus is bimodal. On the one hand, Pol II CTD may serve as a scaffold that brings together the 5′-end of mRNA and CEs, thereby increasing capping efficiency; on the other hand, transcription factors may allosterically enhance the activity of the capping machinery [54].
Capping apparatus has an effect on transcription
The relationship between CEs and transcriptional machinery is mutual [72]. Capping is enhanced by the interaction of CEs with CTD Pol II, but CEs influence transcription as well [28,73–75].
As shown initially, Cet1 inhibits transcriptional reinitiation [73] and lowers the accumulation of Pol II at the promoter-proximal region independent of mRNA capping activity [76]. Ceg1 stimulates early elongation [74,77], with its mutants being defective in this process. The latest findings show that the Cet1–Ceg1 complex and DSIF stimulate Pol II promoter escape and transition to elongation [78].
The yeast methyltransferase Abd1 has a gene-specific stimulatory effect on Pol II recruitment on to a promoter. Stimulation of transcription by Abd1 occurs in a methylation-defective mutant and is therefore independent of capping itself. Conditional mutants in Abd1 have defects in Pol II binding to the promoter at some genes and in promoter clearance or early elongation at other genes. Abd1 depletion results in hyperphosphorylation of CTD Ser5 [74].
The fission yeast cap-methyltransferase Pcm1 recruits P-TEFb to chromatin. When this connection is disrupted, Cdk9 is not properly recruited and Pol II elongation is severely affected [32]. Interaction of Cdk9 with RNA triphosphatase Pct1 has also been described in S. pombe [79].
The distribution of CEs along a gene implies that they influence later stages of transcription. In yeast, genome-wide occupancy for Cet1 and Ceg1 is restricted to the transcription start site, whereas occupancy for Abd1 peaks at 110 bp downstream, and occupancy for the CBC rises subsequently [33]. Presumably, the Ceg1–Cet1 capping apparatus dissociates from the transcription complex as Ser5 phosphorylation decreases during elongation, whereas the yeast Abd1 cap methyltransferase has prolonged interactions with the Pol II CTD.
Human CEs are found at 5′ ends and throughout genes, including even 3′-flanking regions more than a kilobase downstream of the poly(A) site [80]. Capping factors can therefore influence transcription elongation, termination, and 3′-end mRNA processing.
The S. cerevisiae Cet1 N-terminal domain (NTD) promotes the recruitment or facilitates chromatin transcription (FACT), which enhances the engagement of Pol II into transcriptional elongation on an active gene, independently of mRNA capping activity. The absence of the Cet1 NTD impairs FACT targeting and consequently reduces the engagement of Pol II in transcriptional elongation, leading to a promoter-proximal accumulation of Pol II [81].
In mammals, the CE counteracts transcriptional repression with the help of NELF [28,82]. Mammalian RNMT–RAM promotes Pol II-dependent transcription as well. The impact of RNMT–RAM on transcription is direct and independent of mRNA capping, stability, and translation. RNMT–RAM binds the full length of pre-mRNA and recruits proteins associated with transcription [75].
Thus, CEs have been found to regulate transcription independently of their enzymatic activity. The mechanism of this effect seems to be gene- and species-specific.
Another important participant of capping–transcription interplay is the CBC. It has a reciprocal relationship with early transcription events as well. CBC participates in recruiting transcription factors and regulating the transcription process [3]. CBC interacts with CTD kinases in yeast, its depletion affects phosphorylation level of CTD Ser2 and Ser5 [83]. In mammals, CBC stimulates transcription elongation via the recruitment of NELF [84] and P-TEFb and is important for CTD Ser2 phosphorylation [27].
In S. cerevisiae, CBC recruits Ctk2 or Bur2, an ortholog of P-TEFb [83]. Abd1 and CBC are important for the recruitment of kinases Ctk1 and Bur1, which promote elongation and CE release [33].
The mRNA CBC also stimulates the formation of preinitiation complex at the promoter via its interaction with Mot1p in vivo in S. cerevisiae [85]. Mot1p is a regulator of transcription that positively or negatively regulates expression of Pol II-transcribed genes in a gene-specific manner. CBC represses the weak terminator by impeding recruitment of the termination factors Pcf11p and Rna15p (subunits of the cleavage factor CFIA) [86].
Thus, CBC has multiple functions in the transcription process. Recently, polyadenylate-binding protein-interacting protein 2 has been described as a novel partner of CBC. These proteins act jointly at the early elongation stage of transcription, and their depletion affects Ser5 CTD Pol II phosphorylation in Drosophila [87,88].
Capping as a regulatory step in gene expression
Over recent years, examples have emerged to illustrate the regulation of mRNA cap formation by different signals. These signals regulate the rate and extent of mRNA cap formation, resulting in changes in gene expression [89]. The first described case of regulated capping was c-myc-dependent activation [90]. c-Myc regulates the formation of the cap on many transcripts. c-Myc increases the recruitment of catalytically active CE to Pol II and to its target genes [91]. In addition, c-myc causes increased cap methylation, which makes a significant contribution to c-myc-dependent gene regulation, and increased cap methylation is linked to c-myc-dependent enhancement of TFIIH and P-TEFb activity [92]. Since the 7-methylguanosine cap is required for effective translation, the enhanced methyl cap formation also increases protein production from c-myc-responsive genes to a level that exceeds the transcriptional induction. Thus, the regulation of capping is a way to enhance protein synthesis regardless of the transcription augment per se [92,93].
Another example is the E2F1 transcription factor, which promotes the formation of the cap via a mechanism dependent on Pol II phosphorylation [93,94].
Capping is regulated by signaling pathways. For example, RNMT is phosphorylated and activated by CDK1-cyclin B1 during the cell cycle. This results in elevated cap methyltransferase activity, with transcription being reinitiated at the beginning of the postmitotic G1 phase. It is the way to coordinate mRNA capping with the burst of transcription [95]. In yeast, nutrient starvation causes a general decrease in cap methylation [11]. It has been reported that importin-α stimulates general cap methylation [96]. Conversely, CE mRNA-cap positively regulates Hh signaling activity through modulating PKA activity in Drosophila [97].
Thus, the regulatory factors of mRNA capping, together with the capping quality control mechanism, may provide yet another layer of the regulation of gene expression.
Conclusions and prospects
The capping checkpoint model described above has been confirmed in many studies. However, the current model of capping/transcription interplay is not yet complete. There are some issues that need further investigation. An important future challenge is to clarify the cause-and-effect relationships that link capping with transcriptional pausing and elongation. The extensive network of interactions between proteins of capping and transcription machineries is not known in detail. Thus, the mechanism of CBC recruitment on to nascent mRNA is poorly understood, and the same is true of the recruitment of surveillance decapping machinery [98].
Species- and gene-specific interactions are of special interest. Capping and transcription machineries possess some species-specific features [99], e.g. there is a considerable number of metazoan-specific factors and intraspecific paralogs (Table 1). Moreover, non-catalytic regulatory domains of CEs in higher eukaryotes have high diversity even in closely related species. These facts may imply the involvement of these factors and domains in specific interactions with the transcriptional apparatus. Some examples of species-specific connections are mentioned above, including distinct sites of mammalian/yeast CE interaction with phospho-CTD Pol II, different ways of GT–RT interaction with Pol II in budding/fission yeast, the existence of NELF–CE interaction in mammals, and different targets for Abd1/Pcm1 in the transcriptional machinery.
Gene specificity in the functioning of the capping machinery has been described in several cases, such as the aforementioned c-myc- and E2F1-dependent regulation of capping. It may well be that other gene-specific transcription factors can also act in a similar way and regulate local capping [100]. Capping factors may also be a target for gene-specific signaling pathways, as is the NTD of RNMT, which carries multiple modification sites [46,95].
The capping step does not always proceed to completion. An important as yet unanswered question is whether this is simply a consequence of the intrinsic inefficiency of the capping process or a regulated event to modulate subsequent pre-mRNA processing. If the latter is true, what are the components involved, and how are the decisions made as to which pre-mRNAs are to be capped [13]?
The previous model of capping implies that capping plays a ‘passive’ role in regulating gene expression by preventing degradation of mRNAs [101]. Now it is clear that capping can be modulated to ‘actively’ regulate the fate of a bulk or a selected subset of mRNAs. It is still unclear what set of genes and transcription factors participate in regulated capping. More studies are needed to gain a deeper insight into the influence of signaling pathways on capping and the role of regulated capping in the whole context of gene expression.
Abbreviations
- CAPAM
cap-specific adenosine N6-methyltransferase
- CBC
cap-binding protein complex
- Cdf7
cyclin-dependent kinase 7
- CE
capping enzyme
- DSIF
DRB sensitivity-inducing factor
- FACT
facilitates chromatin transcription
- GT
guanylyltransferase
- NELF
negative elongation factor
- NTD
N-terminal domain
- Pol II
RNA Polymerase II
- Pol II CTD
Pol II C-terminal domain
- P-TEFb
positive transcription elongation factor
- RNMT
RNA guanine-N7 methyltransferase
- RT
RNA 5′-triphosphatase
Competing Interests
The authors declare that there are no competing interests associated with the manuscript.
Funding
This work was supported by the Russian Foundation for Basic Research [grant number 18-34-20065].
References
- 1.Furuichi Y. (2015) Discovery of m(7)G-cap in eukaryotic mRNAs. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 91, 394–409 10.2183/pjab.91.394 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Furuichi Y., LaFiandra A. and Shatkin A.J. (1977) 5′-Terminal structure and mRNA stability. Nature 266, 235–239 10.1038/266235a0 [DOI] [PubMed] [Google Scholar]
- 3.Gonatopoulos-Pournatzis T. and Cowling V.H. (2014) Cap-binding complex (CBC). Biochem. J. 457, 231–242 10.1042/BJ20131214 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ramanathan A., Robb G.B. and Chan S.H. (2016) mRNA capping: biological functions and applications. Nucleic Acids Res. 44, 7511–7526 10.1093/nar/gkw551 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gu M., Rajashankar K.R. and Lima C.D. (2010) Structure of the Saccharomyces cerevisiae Cet1-Ceg1 mRNA capping apparatus. Structure 18, 216–227 10.1016/j.str.2009.12.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Takagi T. et al. (2002) Divergent subunit interactions among fungal mRNA 5′-capping machineries. Eukaryot. Cell 1, 448–457 10.1128/EC.1.3.448-457.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ghosh A. and Lima C.D. (2010) Enzymology of RNA cap synthesis. Wiley Interdiscip. Rev. RNA 1, 152–172 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Varshney D. et al. (2016) Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM. Nucleic Acids Res. 44, 10423–10436 10.1093/nar/gkw637 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bueren-Calabuig J.A. et al. (2019) Mechanism of allosteric activation of human mRNA cap methyltransferase (RNMT) by RAM: insights from accelerated molecular dynamics simulations. Nucleic Acids Res. 47, 8675–8692 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Akichika S. et al. (2019) Cap-specific terminal N (6)-methylation of RNA by an RNA polymerase II-associated methyltransferase. Science 363, 10.1126/science.aav0080 [DOI] [PubMed] [Google Scholar]
- 11.Jiao X. et al. (2010) Identification of a quality-control mechanism for mRNA 5′-end capping. Nature 467, 608–611 10.1038/nature09338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Jiao X. et al. (2013) A mammalian pre-mRNA 5′ end capping quality control mechanism and an unexpected link of capping to pre-mRNA processing. Mol. Cell 50, 104–115 10.1016/j.molcel.2013.02.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jurado A.R. et al. (2014) Structure and function of pre-mRNA 5′-end capping quality control and 3′-end processing. Biochemistry 53, 1882–1898 10.1021/bi401715v [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chang J.H. et al. (2012) Dxo1 is a new type of eukaryotic enzyme with both decapping and 5′-3′ exoribonuclease activity. Nat. Struct. Mol. Biol. 19, 1011–1017 10.1038/nsmb.2381 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jimeno-Gonzalez S. et al. (2010) The yeast 5′-3′ exonuclease Rat1p functions during transcription elongation by RNA polymerase II. Mol. Cell 37, 580–587 10.1016/j.molcel.2010.01.019 [DOI] [PubMed] [Google Scholar]
- 16.Xiang S. et al. (2009) Structure and function of the 5′–>3′ exoribonuclease Rat1 and its activating partner Rai1. Nature 458, 784–788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.de Almeida S.F. and Carmo-Fonseca M. (2010) Cotranscriptional RNA checkpoints. Epigenomics 2, 449–455 10.2217/epi.10.21 [DOI] [PubMed] [Google Scholar]
- 18.Orphanides G. and Reinberg D. (2002) A unified theory of gene expression. Cell 108, 439–451 10.1016/S0092-8674(02)00655-4 [DOI] [PubMed] [Google Scholar]
- 19.Kwak H. and Lis J.T. (2013) Control of transcriptional elongation. Annu. Rev. Genet. 47, 483–508 10.1146/annurev-genet-110711-155440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Rasmussen E.B. and Lis J.T. (1993) In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes. Proc. Natl. Acad. Sci. U.S.A. 90, 7923–7927 10.1073/pnas.90.17.7923 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Core L. and Adelman K. (2019) Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation. Genes Dev. 33, 960–982 10.1101/gad.325142.119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wada T. et al. (1998) DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343–356 10.1101/gad.12.3.343 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wada T. et al. (1998) Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17, 7395–7403 10.1093/emboj/17.24.7395 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yamaguchi Y. et al. (1999) NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97, 41–51 10.1016/S0092-8674(00)80713-8 [DOI] [PubMed] [Google Scholar]
- 25.Komarnitsky P., Cho E.J. and Buratowski S. (2000) Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14, 2452–2460 10.1101/gad.824700 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wen Y. and Shatkin A.J. (1999) Transcription elongation factor hSPT5 stimulates mRNA capping. Genes Dev. 13, 1774–1779 10.1101/gad.13.14.1774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lenasi T., Peterlin B.M. and Barboric M. (2011) Cap-binding protein complex links pre-mRNA capping to transcription elongation and alternative splicing through positive transcription elongation factor b (P-TEFb). J. Biol. Chem. 286, 22758–22768 10.1074/jbc.M111.235077 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mandal S.S. et al. (2004) Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 101, 7572–7577 10.1073/pnas.0401493101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cho E.J. et al. (2001) Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev. 15, 3319–3329 10.1101/gad.935901 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ivanov D. et al. (2000) Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20, 2970–2983 10.1128/MCB.20.9.2970-2983.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kim J.B. and Sharp P.A. (2001) Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem. 276, 12317–12323 10.1074/jbc.M010908200 [DOI] [PubMed] [Google Scholar]
- 32.Guiguen A. et al. (2007) Recruitment of P-TEFb (Cdk9-Pch1) to chromatin by the cap-methyl transferase Pcm1 in fission yeast. EMBO J. 26, 1552–1559 10.1038/sj.emboj.7601627 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lidschreiber M., Leike K. and Cramer P. (2013) Cap completion and C-terminal repeat domain kinase recruitment underlie the initiation-elongation transition of RNA polymerase II. Mol. Cell. Biol. 33, 3805–3816 10.1128/MCB.00361-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Schneider S. et al. (2010) Separable functions of the fission yeast Spt5 carboxyl-terminal domain (CTD) in capping enzyme binding and transcription elongation overlap with those of the RNA polymerase II CTD. Mol. Cell. Biol. 30, 2353–2364 10.1128/MCB.00116-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.McCracken S. et al. (1997) 5′-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev. 11, 3306–3318 10.1101/gad.11.24.3306 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zaborowska J., Egloff S. and Murphy S. (2016) The pol II CTD: new twists in the tail. Nat. Struct. Mol. Biol. 23, 771–777 10.1038/nsmb.3285 [DOI] [PubMed] [Google Scholar]
- 37.Yue Z. et al. (1997) Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 94, 12898–12903 10.1073/pnas.94.24.12898 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ho C.K. and Shuman S. (1999) Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol. Cell 3, 405–411 10.1016/S1097-2765(00)80468-2 [DOI] [PubMed] [Google Scholar]
- 39.Harlen K.M. et al. (2016) Comprehensive RNA polymerase II interactomes reveal distinct and varied roles for each phospho-CTD residue. Cell Rep. 15, 2147–2158 10.1016/j.celrep.2016.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Bharati A.P. et al. (2016) The mRNA capping enzyme of Saccharomyces cerevisiae has dual specificity to interact with CTD of RNA Polymerase II. Sci. Rep. 6, 31294 10.1038/srep31294 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Pei Y. et al. (2001) The length, phosphorylation state, and primary structure of the RNA polymerase II carboxyl-terminal domain dictate interactions with mRNA capping enzymes. J. Biol. Chem. 276, 28075–28082 10.1074/jbc.M102170200 [DOI] [PubMed] [Google Scholar]
- 42.Pei Y. and Shuman S. (2002) Interactions between fission yeast mRNA capping enzymes and elongation factor Spt5. J. Biol. Chem. 277, 19639–19648 10.1074/jbc.M200015200 [DOI] [PubMed] [Google Scholar]
- 43.Fabrega C. et al. (2003) Structure of an mRNA capping enzyme bound to the phosphorylated carboxy-terminal domain of RNA polymerase II. Mol. Cell 11, 1549–1561 10.1016/S1097-2765(03)00187-4 [DOI] [PubMed] [Google Scholar]
- 44.Ho C.K. et al. (1998) The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 273, 9577–9585 10.1074/jbc.273.16.9577 [DOI] [PubMed] [Google Scholar]
- 45.Ghosh A., Shuman S. and Lima C.D. (2011) Structural insights to how mammalian capping enzyme reads the CTD code. Mol. Cell 43, 299–310 10.1016/j.molcel.2011.06.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Aregger M. and Cowling V.H. (2013) Human cap methyltransferase (RNMT) N-terminal non-catalytic domain mediates recruitment to transcription initiation sites. Biochem. J. 455, 67–73 10.1042/BJ20130378 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pillutla R.C. et al. (1998) Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA polymerase IIo complexes. J. Biol. Chem. 273, 21443–21446 10.1074/jbc.273.34.21443 [DOI] [PubMed] [Google Scholar]
- 48.Rodriguez C.R. et al. (2000) Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol. Cell. Biol. 20, 104–112 10.1128/MCB.20.1.104-112.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Schroeder S.C. et al. (2000) Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 14, 2435–2440 10.1101/gad.836300 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ebmeier C.C. et al. (2017) Human TFIIH kinase CDK7 regulates transcription-associated chromatin modifications. Cell Rep. 20, 1173–1186 10.1016/j.celrep.2017.07.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Moteki S. and Price D. (2002) Functional coupling of capping and transcription of mRNA. Mol. Cell 10, 599–609 10.1016/S1097-2765(02)00660-3 [DOI] [PubMed] [Google Scholar]
- 52.Nilson K.A. et al. (2015) THZ1 reveals roles for Cdk7 in co-transcriptional capping and pausing. Mol. Cell 59, 576–587 10.1016/j.molcel.2015.06.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Natalizio B.J., Robson-Dixon N.D. and Garcia-Blanco M.A. (2009) The carboxyl-terminal domain of RNA Polymerase II is not sufficient to enhance the efficiency of pre-mRNA capping or splicing in the context of a different polymerase. J. Biol. Chem. 284, 8692–8702 10.1074/jbc.M806919200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Noe Gonzalez M. et al. (2018) CTD-dependent and -independent mechanisms govern co-transcriptional capping of Pol II transcripts. Nat. Commun. 9, 3392 10.1038/s41467-018-05923-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Suh M.H. et al. (2010) A dual interface determines the recognition of RNA polymerase II by RNA capping enzyme. J. Biol. Chem. 285, 34027–34038 10.1074/jbc.M110.145110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Garcia-Lopez M.C. et al. (2011) The conserved foot domain of RNA pol II associates with proteins involved in transcriptional initiation and/or early elongation. Genetics 189, 1235–1248 10.1534/genetics.111.133215 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Garrido-Godino A.I., Garcia-Lopez M.C. and Navarro F. (2013) Correct assembly of RNA polymerase II depends on the foot domain and is required for multiple steps of transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 33, 3611–3626 10.1128/MCB.00262-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Martinez-Rucobo F.W. et al. (2015) Molecular basis of transcription-coupled pre-mRNA capping. Mol. Cell 58, 1079–1089 10.1016/j.molcel.2015.04.004 [DOI] [PubMed] [Google Scholar]
- 59.Doamekpor S.K. et al. (2014) How an mRNA capping enzyme reads distinct RNA polymerase II and Spt5 CTD phosphorylation codes. Genes Dev. 28, 1323–1336 10.1101/gad.242768.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Doamekpor S.K. et al. (2015) Fission yeast RNA triphosphatase reads an Spt5 CTD code. RNA 21, 113–123 10.1261/rna.048181.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Pei Y. et al. (2006) Cyclin-dependent kinase 9 (Cdk9) of fission yeast is activated by the CDK-activating kinase Csk1, overlaps functionally with the TFIIH-associated kinase Mcs6, and associates with the mRNA cap methyltransferase Pcm1 in vivo. Mol. Cell. Biol. 26, 777–788 10.1128/MCB.26.3.777-788.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Tran K. and Gralla J.D. (2010) The TFIIB tip domain couples transcription initiation to events involved in RNA processing. J. Biol. Chem. 285, 39580–39587 10.1074/jbc.M110.171850 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Belanger F. et al. (2010) Characterization of hMTr1, a human Cap1 2′-O-ribose methyltransferase. J. Biol. Chem. 285, 33037–33044 10.1074/jbc.M110.155283 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Werner M. et al. (2011) 2′-O-ribose methylation of cap2 in human: function and evolution in a horizontally mobile family. Nucleic Acids Res. 39, 4756–4768 10.1093/nar/gkr038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Inesta-Vaquera F. et al. (2018) DHX15 regulates CMTR1-dependent gene expression and cell proliferation. Life Sci. Alliance 1, e201800092 10.26508/lsa.201800092 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Sendinc E. et al. (2019) PCIF1 catalyzes m6Am mRNA methylation to regulate gene expression. Mol. Cell 75, 620–630.e9 10.1016/j.molcel.2019.05.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Sun H. et al. (2019) Cap-specific, terminal N(6)-methylation by a mammalian m(6)Am methyltransferase. Cell Res. 29, 80–82 10.1038/s41422-018-0117-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Hirose Y. et al. (2008) Human phosphorylated CTD-interacting protein, PCIF1, negatively modulates gene expression by RNA polymerase II. Biochem. Biophys. Res. Commun. 369, 449–455 10.1016/j.bbrc.2008.02.042 [DOI] [PubMed] [Google Scholar]
- 69.Boulias K. et al. (2019) Identification of the m(6)Am methyltransferase PCIF1 reveals the location and functions of m(6)Am in the transcriptome. Mol. Cell 75, 631–643.e8 10.1016/j.molcel.2019.06.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Cowling V.H. (2019) CAPAM: the mRNA cap adenosine N6-methyltransferase. Trends Biochem. Sci. 44, 183–185 10.1016/j.tibs.2019.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Mauer J. et al. (2017) Reversible methylation of m(6)Am in the 5′ cap controls mRNA stability. Nature 541, 371–375 10.1038/nature21022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Perales R. and Bentley D. (2009) “Cotranscriptionality”: the transcription elongation complex as a nexus for nuclear transactions. Mol. Cell 36, 178–191 10.1016/j.molcel.2009.09.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Myers L.C. et al. (2002) The yeast capping enzyme represses RNA polymerase II transcription. Mol. Cell 10, 883–894 10.1016/S1097-2765(02)00644-5 [DOI] [PubMed] [Google Scholar]
- 74.Schroeder S.C. et al. (2004) A function of yeast mRNA cap methyltransferase, Abd1, in transcription by RNA polymerase II. Mol. Cell 13, 377–387 10.1016/S1097-2765(04)00007-3 [DOI] [PubMed] [Google Scholar]
- 75.Varshney D. et al. (2018) mRNA cap methyltransferase, RNMT-RAM, promotes RNA Pol II-dependent transcription. Cell Rep. 23, 1530–1542 10.1016/j.celrep.2018.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Lahudkar S. et al. (2014) A novel role for Cet1p mRNA 5′-triphosphatase in promoter proximal accumulation of RNA polymerase II in Saccharomyces cerevisiase. Genetics 196, 161–176 10.1534/genetics.113.158535 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Kim H.J. et al. (2004) mRNA capping enzyme activity is coupled to an early transcription elongation. Mol. Cell. Biol. 24, 6184–6193 10.1128/MCB.24.14.6184-6193.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Fujiwara R. et al. (2019) The capping enzyme facilitates promoter escape and assembly of a follow-on preinitiation complex for reinitiation. Proc. Natl. Acad. Sci. U.S.A. 116, 22573–22582 10.1073/pnas.1905449116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Pei Y., Schwer B. and Shuman S. (2003) Interactions between fission yeast Cdk9, its cyclin partner Pch1, and mRNA capping enzyme Pct1 suggest an elongation checkpoint for mRNA quality control. J. Biol. Chem. 278, 7180–7188 10.1074/jbc.M211713200 [DOI] [PubMed] [Google Scholar]
- 80.Glover-Cutter K. et al. (2008) RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat. Struct. Mol. Biol. 15, 71–78 10.1038/nsmb1352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Sen R. et al. (2017) An mRNA capping enzyme targets FACT to the active gene to enhance the engagement of RNA polymerase II into transcriptional elongation. Mol. Cell. Biol. 37, pii: e00029 10.1128/MCB.00029-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Kaneko S. et al. (2007) Human capping enzyme promotes formation of transcriptional R loops in vitro. Proc. Natl. Acad. Sci. U.S.A. 104, 17620–17625 10.1073/pnas.0708866104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Hossain M.A. et al. (2013) The yeast cap binding complex modulates transcription factor recruitment and establishes proper histone H3K36 trimethylation during active transcription. Mol. Cell. Biol. 33, 785–799 10.1128/MCB.00947-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Narita T. et al. (2007) NELF interacts with CBC and participates in 3′ end processing of replication-dependent histone mRNAs. Mol. Cell 26, 349–365 10.1016/j.molcel.2007.04.011 [DOI] [PubMed] [Google Scholar]
- 85.Lahudkar S. et al. (2011) The mRNA cap-binding complex stimulates the formation of pre-initiation complex at the promoter via its interaction with Mot1p in vivo. Nucleic Acids Res. 39, 2188–2209 10.1093/nar/gkq1029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Wong C.M. et al. (2007) Yeast cap binding complex impedes recruitment of cleavage factor IA to weak termination sites. Mol. Cell. Biol. 27, 6520–6531 10.1128/MCB.00733-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Kachaev Z.M. et al. (2018) Paip2 is localized to active promoters and loaded onto nascent mRNA in Drosophila. Cell Cycle 17, 1708–1720 10.1080/15384101.2018.1496738 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Kachaev Z.M. et al. (2019) Paip2 cooperates with Cbp80 at an active promoter and participates in RNA Polymerase II phosphorylation in Drosophila. FEBS Lett. 593, 1102–1112 10.1002/1873-3468.13391 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Galloway A. and Cowling V.H. (2019) mRNA cap regulation in mammalian cell function and fate. Biochim. Biophys. Acta Gene Regul. Mech. 1862, 270–279 10.1016/j.bbagrm.2018.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Cowling V.H. and Cole M.D. (2007) The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol. Cell. Biol. 27, 2059–2073 10.1128/MCB.01828-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Lombardi O. et al. (2016) c-Myc deregulation induces mRNA capping enzyme dependency. Oncotarget 7, 82273–82288 10.18632/oncotarget.12701 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Cowling V.H. and Cole M.D. (2010) Myc regulation of mRNA cap methylation. Genes Cancer 1, 576–579 10.1177/1947601910378025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Cole M.D. and Cowling V.H. (2009) Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors. Oncogene 28, 1169–1175 10.1038/onc.2008.463 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Aregger M. and Cowling V.H. (2012) E2F1-dependent methyl cap formation requires RNA pol II phosphorylation. Cell Cycle 11, 2146–2148 10.4161/cc.20620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Aregger M. et al. (2016) CDK1-cyclin B1 activates RNMT, coordinating mRNA cap methylation with G1 phase transcription. Mol. Cell 61, 734–746 10.1016/j.molcel.2016.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Wen Y. and Shatkin A.J. (2000) Cap methyltransferase selective binding and methylation of GpppG-RNA are stimulated by importin-alpha. Genes Dev. 14, 2944–2949 10.1101/gad.848200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Chen P. et al. (2017) Capping enzyme mRNA-cap/RNGTT regulates hedgehog pathway activity by antagonizing protein kinase A. Sci. Rep. 7, 2891 10.1038/s41598-017-03165-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Zhai L.T. and Xiang S. (2014) mRNA quality control at the 5′ end. J. Zhejiang Univ. Sci. B. 15, 438–443 10.1631/jzus.B1400070 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Shuman S. (2002) What messenger RNA capping tells us about eukaryotic evolution. Nat. Rev. Mol. Cell Biol. 3, 619–625 10.1038/nrm880 [DOI] [PubMed] [Google Scholar]
- 100.Dunn S. and Cowling V.H. (2015) Myc and mRNA capping. Biochim. Biophys. Acta 1849, 501–505 10.1016/j.bbagrm.2014.03.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Aregger M. and Cowling V.H. (2017) Regulation of mRNA capping in the cell cycle. RNA Biol. 14, 11–14 10.1080/15476286.2016.1251540 [DOI] [PMC free article] [PubMed] [Google Scholar]

